(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 11.59% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.17%.
Radnet's revenue in 2026 is $2,268,932,000.On average, 11 Wall Street analysts forecast RDNT's revenue for 2026 to be $201,386,280,663, with the lowest RDNT revenue forecast at $190,840,848,225, and the highest RDNT revenue forecast at $209,334,703,620. On average, 10 Wall Street analysts forecast RDNT's revenue for 2027 to be $223,106,723,595, with the lowest RDNT revenue forecast at $204,691,565,457, and the highest RDNT revenue forecast at $237,980,505,168.
In 2028, RDNT is forecast to generate $242,466,248,817 in revenue, with the lowest revenue forecast at $215,551,786,923 and the highest revenue forecast at $258,992,672,787.